These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 22203179)
1. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma. Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179 [TBL] [Abstract][Full Text] [Related]
2. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus. Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396 [TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma. Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352 [TBL] [Abstract][Full Text] [Related]
4. Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma. Cao X; Li Y; Luo RZ; He LR; Yang J; Zeng MS; Wen ZS Ann Thorac Surg; 2012 May; 93(5):1674-80. PubMed ID: 22429674 [TBL] [Abstract][Full Text] [Related]
5. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification. Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107 [TBL] [Abstract][Full Text] [Related]
6. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma. Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of Raf-1 kinase inhibitory protein predicts regional lymph node metastasis and shorter survival in esophageal squamous cell carcinoma. Kim HS; Won KY; Kim GY; Kim SC; Park YK; Kim YW Pathol Res Pract; 2012 May; 208(5):292-9. PubMed ID: 22464151 [TBL] [Abstract][Full Text] [Related]
8. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy. Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma. Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis. Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252 [TBL] [Abstract][Full Text] [Related]
11. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma. Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Sox3 is associated with diminished prognosis in esophageal squamous cell carcinoma. Li K; Wang RW; Jiang YG; Zou YB; Guo W Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S459-66. PubMed ID: 23238694 [TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma. Luo KJ; Wen J; Xie X; Fu JH; Luo RZ; Wu QL; Hu Y Ann Thorac Surg; 2012 May; 93(5):1682-8. PubMed ID: 22480390 [TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
15. Significance of lymph node capsular invasion in esophageal squamous cell carcinoma. Sakai M; Suzuki S; Sano A; Tanaka N; Inose T; Sohda M; Nakajima M; Miyazaki T; Kuwano H Ann Surg Oncol; 2012 Jun; 19(6):1911-7. PubMed ID: 22290569 [TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722 [TBL] [Abstract][Full Text] [Related]
17. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus. Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507 [TBL] [Abstract][Full Text] [Related]
18. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma. Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519 [TBL] [Abstract][Full Text] [Related]
19. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy? Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322 [TBL] [Abstract][Full Text] [Related]
20. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]